References:
- Ferguson et al (2020), “Impact of non-pharmaceutical interventions
(NPIs) to reduce COVID- 19 mortality and healthcare demand”, Imperial
College COVID 19 Response team report, 16 March 2020.
- Dion Bongaerts, Francesco Mazzola and Wolf Wagner (2020), “Closed for
Business”, CEPR Discussion Paper 14814, May 2020.
- José Lourenço, Robert Paton, Mahan Ghafari,Moritz Kraeme,
Craig Thompson, Peter Simmonds, Paul Klenerman, Sunetra Gupta
(2020), “Fundamental principles of epidemic spread highlight the
immediate need for large-scale serological surveys to assess the stage
of the SARS-CoV-2 epidemic “, medRxiv preprint doi:
https://doi.org/10.1101/2020.03.24.20042291, March 2020.
- Mike Stedman, Mark Davies, Mark Lunt, Arpana Verma, Simon G. Anderson
and Adrian H Heald (2020), “A phased approach to unlocking during the
COVID-19 pandemic – Lessons from trend analysis”. Int J Clin Pract.
2020 May 7:e13528. doi: 10.1111/ijcp.13528.
- Oscar Dimdore-Miles and David Miles (2020), “Assessing the Spread of
the Novel Coronavirus In The Absence of Mass Testing”, Covid
Economics, issue 16, pages 161-176, May 2020.
- T. Wieland (2020) “Flatten the Curve! Modelling SARS-CoV-2/COVID-19
Growth in Germany on the County Level”, pre-print available at
https://www.medrxiv.org/content/10.1101/2020.05.14.20101667v2.
- Karl J. Friston, Thomas Parr, Peter Zeidman, Adeel Razi, Guillaume
Flandin, Jean Daunizeau, Oliver J. Hulme, Alexander J. Billig,
Vladimir Litvak, Rosalyn J. Moran, Cathy J. Price and Christian
Lambert (2020) “Dynamic Causal Modelling of COVID 19”, Technical
Report available at
https://arxiv.org/ftp/arxiv/papers/2004/2004.04463.pdf.
- Michael Levitt (2020) “The Corona Chronologies” available at:
“https://www.dropbox.com/s/r4gxdvlcnrxet1i/1.The_Corona_Chronologies.%20Part%20I%20-%20China.%20Part%20II.%20Rest_of_World_Michael_Levitt%2CStanford_r.pdf?dl=0.
- Benjamin Born, Alexander M. Dietrich and Gernot J. Müller (2020), “Do
lockdowns work? A counterfactual for Sweden”, Covid Economics, issue
16, May 2020.
- Dirk Krueger, Harald Uhlig and Taojun Xie (2020), “Macroeconomic
dynamics and reallocation in an epidemic”, Covid Economics, vol 5,
April 2020.
- https://www.ft.com/content/a26fbf7e-48f8-11ea-aeb3-955839e06441:
accessed 12 June 2020
- Pragyan Deb, Davide Furceri, Jonathan D. Ostry and Nour Tawk (2020),
“The economic effects of Covid-19 containment measures”. COVID
Economics, CEPR, vol 24. May 2020.
- Barthélémy Bonadio, Zhen Huo, Andrei A. Levchenko, Nitya
Pandalai-Nayar (2020), “Global Supply Chains in the Pandemic”, NBER
Working Paper 27224, May 2020.
- Sangmin Aum, Sang Yoon (Tim) Lee, Yongseok Shin (2020),
“Doesn’t
Need Lockdowns to Destroy Jobs: The Effect of Local Outbreaks in
Korea”, CEPR Discussion Paper 14822.
- Olivier Coibion, Yuriy Gorodnichenko and Michael Weber (a, 2020),
“Labor markets during the Covid-19 crisis: A preliminary view”,
COVID Economics, vol 21. May 2020, a.
- Olivier Coibion, Yuriy Gorodnichenko and Michael Weber (b, 2020),
“The cost of the COVID-19 crisis: Lockdowns, macroeconomic
expectations, and consumer spending”, Covid Economics, issue 20, May
2020.
- https://www.bankofengland.co.uk/-/media/boe/files/monetary-policy-report/2020/may/monetary-policy-report-may-2020#:accessed 11 June 2020.
- http://www.pulsetoday.co.uk/clinical/clinical-specialties/respiratory-/gp-urgent-cancer-referrals-decline-by-more-than-70-as-fewer-patients-come-forward/20040662.article:
accessed 11 June 2020.
- https://www.england.nhs.uk/statistics/statistical-work-areas/hospital-activity/monthly-hospital-activity/mar-data/:
accessed 11 June 2020.
- NICE (2013), “How NICE measures value for money in relation to public
health interventions”, Published: 1 September 2013 at:
nice.org.uk/guidance/lgb10.
- https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/datasets/nationallifetablesunitedkingdomreferencetables:
accessed 10 June 2020.
- Jonathan Valabhji, Naomi Holman, Peter Knighton, Partha Kar, Jackie
O’Keefe, Matt Curley, Andy Weaver, Emma Barron, Chirag Bakhai, Kamlesh
Khunti, Nick Wareham, Naveed Sattar, Bob Young (2020) “ Type 1 and
Type 2 diabetes and COVID-19 related mortality in England: a cohort
study in people with diabetes”, preprint available at
https://www.england.nhs.uk/wp-content/uploads/2020/05/Valabhji-COVID-19-and-Diabetes-Paper-2-Full-Manuscript.pdf.
- https://digital.nhs.uk/data-and-information/publications/statistical/national-diabetes-audit/report-2--complications-and-mortality-2017-18:
accessed 10 June 2020.
- Clarke P, Gray A, Holman R. (2002) “Estimating utility values for
health states of type 2 diabetic patients using the EQ-5D (UKPDS
62)”. Med Decision Making. 22: pages 340-349
- A Beaudet, J Clegg, P Thuresson, A Lloyd, P McEwan (2014) “Review of
Utility Values for Economic Modeling in Type 2 Diabetes”, Value in
Health,
Volume
17, Issue 4, June 2014, Pages 462-470
- Arulampalam, W, P Gregg and M Gregory (2001), “Unemployment
Scarring”, The Economic Journal 111(475): F577-F584
- Tumino, A (2015), “The scarring effect of unemployment from the early
‘90s to the Great Recession”, Institute for Economic and Social
Research Working Paper 2015
- Carol
Propper, George
Stoye and Ben
Zaranko (2020), “The wider impacts of the coronavirus pandemic on
the NHS”, IFS briefing (available at
https://www.ifs.org.uk/publications/14798), April 2020.
- E P Gentry, W K Viscusi. The fatality and morbidity components of the
value of a statistical life. Journal of Health Economics, volume 46,
p. 90 – 99.
- Kevin M. Murphy and Robert H. Topel. The Value of Health and
Longevity. Journal of Political Economy 2006 114:5, 871-904.
- Joshua R. Goldstein and Ronald D. Lee (2020), “ Demographic
Perspectives on Mortality of COVID-19 and other Pandemics”, NBER
Working Paper 27043.